VANGUARD 7 liofilizado y suspension para suspension inyectable para perros
VANGUARD 7 liofilizado y suspension para suspension inyectable para perros
Authorised
- Canine distemper virus, strain N-CDV, Live
- Canine adenovirus 2, strain Manhattan, Live
- Canine parainfluenza virus, strain NL-CPI-5, Live
- Canine parvovirus, strain NL-35-D, Live
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated
Product identification
Medicine name:
VANGUARD 7 liofilizado y suspension para suspension inyectable para perros
Active substance:
- Canine distemper virus, strain N-CDV, Live
- Canine adenovirus 2, strain Manhattan, Live
- Canine parainfluenza virus, strain NL-CPI-5, Live
- Canine parvovirus, strain NL-35-D, Live
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine distemper virus, strain N-CDV, Live3.00cell culture infective dose 501.00Dose
-
Canine adenovirus 2, strain Manhattan, Live3.20cell culture infective dose 501.00Dose
-
Canine parainfluenza virus, strain NL-CPI-5, Live6.00cell culture infective dose 501.00Dose
-
Canine parvovirus, strain NL-35-D, Live7.00cell culture infective dose 501.00Dose
-
Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated80.00percentage protection1.00Dose
-
Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated80.00percentage protection1.00Dose
Pharmaceutical form:
-
Lyophilisate and suspension for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AI02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Spain
Available in:
-
Spain
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Spain S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium
Responsible authority:
- Spanish Agency For Medicines And Medical Devices
Authorisation number:
- 3121 ESP
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 29/11/2023
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 29/11/2023
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 29/11/2023
How useful was this page?: